Skip to content Skip to footer
Subscribe Now
Disease of the Month - Pancreatic Cancer
INSIGHTS+

Disease of the Month – Pancreatic Cancer

Shots To keep our readers acquainted with several disease conditions, ongoing trials, and available treatment options, PharmaShots brings every month a detailed take on a particular disease after thorough research   Continuing the series for the Disease of the Month, PharmaShots brings a condensed report on Pancreatic Cancer  November 16th is observed as World Pancreatic Cancer…
December 18, 2023

Read more

VIEWPOINTS_Helen Yeh1_Naim Shehadeh2_2023
VIEWPOINTS

Helen Yeh & Naim Shehadeh in a Stirring Conversation with PharmaShots, Highlight the Results from T2NOW Study

Shots: At the EASD, AZ announced positive results from the T2NOW P-III study that evaluated the efficacy and safety of Forxiga as an add-on treatment in children and adolescents with T2D receiving metformin, insulin, or both Helen Yeh, VP, CVRM Therapy Area Biopharmaceuticals Medical at AstraZeneca, and Naim Shehadeh, Professor of Endocrinology, Rambam Health Care…
December 11, 2023

Read more

Webinar Recap Successful Drug Discovery-Collaboration Among Multiple Functions
EVENTS

Webinar Recap: Successful Drug Discovery-Collaboration Among Multiple Functions

Illuminating, informative, and engaging, our recent webinar on Successful Drug Discovery-Collaboration Among Multiple Functions with Eurofins Advinus, was an energy-packed session that highlighted the intricacies of the drug discovery process. The webinar delved deep into the nuances that are necessary for a successful drug discovery. The session was filled with stimulating case studies, highlighting crucial aspects like…
December 8, 2023

Read more

VIEWPOINTS_Kylen Cieslak1_Robert Ley2_2023
VIEWPOINTS

Kylen Cieslak and Robert Ley Discuss the Expansion of Thermo Fisher Scientific’s Services Central in the US & EU

Shots:  Kylen Cieslak, Senior Manager, Service Marketing, Thermo Fisher Scientific, and Robert Ley, Senior Strategic Product Manager, Thermo Fisher Scientific in a stirring conversation with PharmaShots   Kylen and Robert highlighted the recent expansion of Thermo Fisher Scientific’s Services Central in the United States and Europe   Services Central is an online platform intended to provide 24/7…
December 7, 2023

Read more

VIEWPOINTS_Betty Woo_2023
VIEWPOINTS

In an Insightful Conversation with PharmaShots, Betty Woo Highlights Thermo Fisher’s Cell Therapy Collaboration Program

Shots:   Betty Woo, VP of Cell, Gene, and Advanced Therapies, Thermo Fisher Scientific discusses the evolution of ThermoFisher’s strategic collaboration with ArsenalBio    Betty highlights the development of programmable autologous T cells for the treatment of cancer and the cell therapy collaboration program   Betty believes that through innovation and partnership, they can tap into the full…
November 30, 2023

Read more

Top Performing Drug – Cosentyx (November Edition)
INSIGHTS+

Top Performing Drug – Cosentyx (November Edition)

Shots:   In continuation of our previous series on the Top-Performing Drug of the month, based on 2021 revenue, this month we have selected Cosentyx and prepared a curated analysis report for our readers  Cosentyx is indicated for the treatment of psoriasis, ankylosing spondylitis, and psoriatic arthritis. It is a human IgG1κ mAb which targets interleukin (IL)-17A    PharmaShots presents a…
November 22, 2023

Read more

VIEWPOINTS_Matthew G. Fishler_2023
VIEWPOINTS

Matthew G. Fishler Shares the Highlights of AVEIR DR, the World’s First Dual-Chamber Leadless Pacemaker System

Shots:  Matthew G. Fishler, Chief Engineer and Director of Product Development Abbott’s Cardiac Rythm Management Business, in an insightful conversation with PharmaShots   Matthew shares the highlights of the recently approved AVEIR Dr, the world’s first dual-chamber leadless pacemaker system for patients with slower-than-normal or abnormal heart rhythms   Equipped with i2i™ communication technology, AVIER DR eliminates…
November 20, 2023

Read more

VIEWPOINTS_Jane Reed_2023
VIEWPOINTS

Jane Reed Highlights the Growing Dependence of NLP to Comply with the Regulatory Guidelines

Shots:  In an invigorating conversation with PharmaShots, Jane Reed discusses the transition from document-driven to data-driven decision-making in the pharmaceutical industry   Jane sheds light on the increasing dependence on AI and ML in regulatory affairs and how it helps pharma companies mitigate errors, discrepancies, and non-compliance   Jane highlights the benefits of NLP in ensuring regulatory…
November 16, 2023

Read more

PharmaShots Magazine-November 2023 Edition
MAGAZINE

PharmaShots Magazine-November 2023 Edition

Health is not a commodity, it’s an indispensable human right that must know no boundary of gender, race, or socio-economic status. Health for all is an all-inclusive mission by the WHO that aims to reduce preventable mortalities and morbidities by providing healthcare provisions in every area. Women health is still a concerning topic in under-developed and…
November 10, 2023

Read more

VIEWPOINTS_Dr. Jay Backstrom_2023
VIEWPOINTS

Dr. Jay Backstrom shares insights from the Phase II TOPAZ trial for the treatment of SMA

Shots:  Dr. Jay Backstrom in an engaging conversation with PharmaShots, shares the highlights of the P-II Topaz trial designed to evaluate the safety and efficacy of apitegromab for the treatment of Spinal Muscle Atrophy (Type 2 & 3)   With the potential to transform care in SMA by directly addressing progressive muscle weakness, apitegromab aims to…
November 7, 2023

Read more

Load more